Abstract
Hypothesis: The study was designed to establish a lack of relationship between chronic C. pneumoniae infection and CHD.
Methods: Chlamydia‐specific IgG‐antibody was assayed using an indirect immunofluorescence test in the serum of 159 patients with severe arterial disease and 203 patients with a heart valve prostheses and no demonstrable CHD. Fatal and nonfatal vascular events and systemic thromboembolism were recorded over a 2‐year period.
Results: In the arterial group 107 patients (67.3%) and in the valvular group 120/203 (59.1%) were positive for C. pneumoniae antibody. The number of patients with fatal or nonfatal vascular events (double end point) in the arterial and valvular groups was 23 and 2, respectively (p<.0001). Triple end points (fatal plus nonfatal vascular events plus thromboembolism) were also more frequent in the arterial group (p< 0.002). The prevalence of chlamydia antibody positivity was the same in the arterial and valvular groups, and the occurrence of clinical events was also the same for chlamydia‐positive (227 patients) as for chlamydia‐negative (135 patients). After adjustment for confounding variables, only arterial disease was a predictive factor for double (OR 17.0; 95% CI 3.94–73.3) or triple (OR 3.12; 95% CI 1.56–6.25) end points.
Conclusion: We find C. pneumoniae chronic infection not to be an independent risk factor for acute or chronic arterial disease.
Keywords: Chlamydia pneumoniae, coronary disease, atherosclerosis
Full Text
The Full Text of this article is available as a PDF (550.5 KB).
References
- 1. Metha JL, Saldeen TGP, Rand K: Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998; 31: 1217–1225 [DOI] [PubMed] [Google Scholar]
- 2. Linnanmäki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P: Chlamydia pneumoniae‐specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993. 87: 1130–1134 [DOI] [PubMed] [Google Scholar]
- 3. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Vatonen V: Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983–985 [DOI] [PubMed] [Google Scholar]
- 4. Thorn DH, Grayston T, Siscovick DS, Wang S, Weiss NS, Daling JR: Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. J Am Med Assoc 1992; 268: 68–72 [PubMed] [Google Scholar]
- 5. Thom DH, Wang SP, Grayston T, Siscovick DS, Stewart DK, Kronmal RA, Weiss NS: Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991; 11: 547–551 [DOI] [PubMed] [Google Scholar]
- 6. Saikku P, Leinonen M, Tenkanen L, Linnanmäki E, Ekman M, Manninen V, Mäntäri M, Frick MH, Huttunen JK: Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116: 274–278 [DOI] [PubMed] [Google Scholar]
- 7. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ: Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997; 96: 404–407 [DOI] [PubMed] [Google Scholar]
- 8. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, Woods ML, Anderson JL: Increased incidence of chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996; 27: 1555–1561 [DOI] [PubMed] [Google Scholar]
- 9. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP: Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15–34 years old). Proc Natl Acad Sci USA, 1995; 92: 6911–6914 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Grayston JT, Kuo C, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, Strandness ED, Wang S: Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995; 92: 3397–3400 [DOI] [PubMed] [Google Scholar]
- 11. Ramirez JA, and The Chlamydia pneumoniae/atherosclerosis study group : Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 1996; 125: 979–982 [DOI] [PubMed] [Google Scholar]
- 12. Chiu B, Viira E, Tucker W, Fong IW: Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997; 96: 2144–2148 [DOI] [PubMed] [Google Scholar]
- 13. Muhlestein JB, Anderson JL, Hammond EH, Zhao L, Trehan S, Schwobe EP, Carlquist JF: Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998; 97: 633–636 [DOI] [PubMed] [Google Scholar]
- 14. Godzik KL, O'Brien ER, Wang SK, Kuo C: In vitro susceptibility of human vascular wall cells to infection with. Chlamydia pneumoniae. J Clin Microbiol 1995; 33: 2411–2414 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Altman R, Rouvier J, Gurfinkel E, Scazziota A, Turpie AGG: Comparison of high‐dose with low‐dose aspirin in patients with mechanical heart valve replacement treated with oral anticoagulant. Circulation 1996; 94: 2113–2116 [DOI] [PubMed] [Google Scholar]
- 16. Hahn DL, Golubjatnikov R: Smoking is a potential confounder of the Chlamydia pneumoniae‐coronary artery disease association. Arteroscler Thromb 1992; 12: 945–947 [DOI] [PubMed] [Google Scholar]
- 17. Tong CYW, Potter F, Worthington E, Mullins P: Chlamydia pneumoniae myocarditis. Lancet 1995; 346: 710–711 [DOI] [PubMed] [Google Scholar]
- 18. Gurfinkel E, Duronto E, Cerda M, Gomez Carretero L, Bozovich G, Rosloznik J, Daroca A, Mautner B: Patients with unstable angina related with C reactive protein and Chlamydia pneumoniae infection (abstr). Eur Heart J 1996. (suppl); 17: 578 [Google Scholar]
- 19. Wesslen L, Pahlson C, Friman G, Fohlman J, Lindquist O, Johansson: Myocarditis caused by Chlamydia pneumoniae (TWAR) and sudden unexpected death in a Swedish elite orienteer. Lancet 1992; 340: 427–428 [DOI] [PubMed] [Google Scholar]
- 20. Campbell LA, Moazed TC, Kuo CC, Grayston JT: Mouse models of atherosclerosis and Chlamydia pneumoniae (abstr). Proc Third Eur Soc Chlam Res 1996; 3: 106 [Google Scholar]
- 21. Patel P, Carrington D, Strachan DP, Leatham E, Goggin P, Northfield TC, Mendall MA: Fibrinogen: A link between chronic infection and coronary heart disease. Lancet 1994; 343: 1634–1635 [DOI] [PubMed] [Google Scholar]
- 22. Libby P, Egan D, Skarlatos S: Roles of infectious agents in atherosclerosis and restenosis. Circulation 1997; 96: 4095–4103 [DOI] [PubMed] [Google Scholar]
- 23. Danesh J, Collins R, Peto R: Chronic infections and coronary heart disease: Is there a link? Lancet 1997; 350: 430–436 [DOI] [PubMed] [Google Scholar]